Erratum: Human Anti-CXCR4 Antibodies Undergo VH Replacement, Exhibit Functional V-Region Sulfation, and Dene CXCR4 Antigenic Heterogeneity (J Immunol. (2007) 179 ( 2408-2418) DOI: 10.4049/jimmunol.179.4.2408);Human anti-CXCR4 antibodies undergo VH replacement, exhibit functional V-region sulfation, and define CXCR4 antigenic heterogeneity

Journal of Immunology

Volumn 179, Issue 4, 2007, Pages 2408-2418

  Xu, Chen ^a   Sui, Jianhua ^a   Tao, Hong ^a   Zhu, Quan ^a   Marasco, Wayne A ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR4 ANTIBODY; EPITOPE; PLERIXAFOR; STROMAL CELL DERIVED FACTOR 1; TYROSINE; UNCLASSIFIED DRUG; ALPHA CHEMOKINE; AUTOANTIBODY; ISOPROTEIN;

ANIMAL CELL; ARTICLE; AUTOIMMUNE DISEASE; BINDING AFFINITY; CHEMOTAXIS; CONTROLLED STUDY; FLOW CYTOMETRY; GENE; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC HETEROGENEITY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; PROTEIN ISOLATION; PROTEIN STRUCTURE; PROTEOLIPOSOME; SULFATION; VH GENE; ANIMAL; CELL LINE; DOG; EPITOPE MAPPING; HOMEOSTASIS; IMMUNOLOGY; PATHOLOGY; PROTEIN PROCESSING;

ANIMALS; AUTOANTIBODIES; AUTOIMMUNE DISEASES; CELL LINE; CHEMOKINES, CXC; DOGS; EPITOPE MAPPING; EPITOPES; HOMEOSTASIS; HUMANS; PROTEIN ISOFORMS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTORS, CXCR4;

EID: 34848879175     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.2400188     Document Type: Erratum

References (67)

1. Juarez, J., L. Bendall, and K. Bradstock. 2004. Chemokines and their receptors as therapeutic targets: the role of the SDF-1/CXCR4 axis. Curr. Pharm. Des. 10: 1245-1259.
2. Knaut, H., C. Werz, R. Geisler, and C. Nusslein-Volhard. 2003. A zebrafish homologue of the chemokine receptor Cxcr4 is a germ-cell guidance receptor. Nature 421: 279-282.
3. Murdoch, C. 2000. CXCR4: chemokine receptor extraordinaire. Immunol. Rev. 177: 175-184.
4. Rossi, D., and A. Zlotnik. 2000. The biology of chemokines and their receptors. Annu. Rev. Immunol. 18: 217-242.
5. Sallusto, F., C. R. Mackay, and A. Lanzavecchia. 2000. The role of chemokine receptors in primary, effector, and memory immune responses. Annu. Rev. Immunol. 18: 593-620.
6. Muller, A., B. Homey, H. Soto, N. Ge, D. Catron, M. E. Buchanan, T. McClanahan, E. Murphy, W. Yuan, S. N. Wagner, et al. 2001. Involvement of chemokine receptors in breast cancer metastasis. Nature 410: 50-56.
7. Murakami, T., W. Maki, A. R. Cardones, H. Fang, A. Tun Kyi, F. O. Nestle, and S. T. Hwang. 2002. Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells. Cancer Res. 62: 7328-7334.
8. Zeelenberg, I. S., L. Ruuls-Van Stalle, and E. Roos. 2003. The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases. Cancer Res. 63: 3833-3839.
9. Burger, J. A., and T. J. Kipps. 2006. CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. Blood. 107: 1761-1767.
10. Kakinuma, T., and S. T. Hwang. 2006. Chemokines, chemokine receptors, and cancer metastasis. J. Leukocyte Biol. 79: 639-651.
11. Balkwill, F. 2004. Cancer and the chemokine network. Nat. Rev. Cancer 4: 540-550.
12. Balkwill, F. 2004. The significance of cancer cell expression of the chemokine receptor CXCR4. Semin. Cancer Biol. 14: 171-179.
13. Zlotnik, A. 2004. Chemokines in neoplastic progression. Semin. Cancer Biol. 14: 181-185.
14. Ratajczak, M. Z., E. Zuba-Surma, M. Kucia, R. Reca, W. Wojakowski, and J. Ratajczak. 2006. The pleiotropic effects of the SDF-1-CXCR4 axis in organogenesis, regeneration and tumorigenesis. Leukemia 20: 1915-1924.
15. Berger, E. A., P. M. Murphy, and J. M. Farber. 1999. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu. Rev. Immunol. 17: 657-700.
16. Doms, R. W. 2001. Chemokine receptors and HIV entry. AIDS 15(Suppl. 1): S34-S35.
17. Kryczek, I., S. Wei, E. Keller, R. Liu, and W. Zou. 2006. Stromal derived factor (SDF-1/CXCL12) and human tumor pathogenesis. Am. J. Physiol. 292: C987-C995.
18. Chabot, D. J., H. Chen, D. S. Dimitrov, and C. C. Broder. 2000. N-linked glycosylation of CXCR4 masks coreceptor function for CCR5-dependent human immunodeficiency virus type 1 isolates. J. Virol. 74: 4404-4413.
19. Sloane, A. J., V. Raso, D. S. Dimitrov, X. Xiao, S. Deo, N. Muljadi, D. Restuccia, S. Turville, C. Kearney, C. C. Broder, et al. 2005. Marked structural and functional heterogeneity in CXCR4: separation of HIV-1 and SDF-1α responses. Immunol Cell. Biol. 83: 129-143.
20. Wang, J., G. J. Babcock, H. Choe, M. Farzan, J. Sodroski, and D. Gabuzda. 2004. N-linked glycosylation in the CXCR4 N-terminus inhibits binding to HIV-1 envelope glycoproteins. Virology 324: 140-150.
21. Chabot, D. J., P. F. Zhang, G. V. Quinnan, and C. C. Broder. 1999. Mutagenesis of CXCR4 identifies important domains for human immunodeficiency virus type 1 X4 isolate envelope-mediated membrane fusion and virus entry and reveals cryptic coreceptor activity for R5 isolates. J. Virol. 73: 6598-6609.
22. Farzan, M., G. J. Babcock, N. Vasilieva, P. L. Wright, E. Kiprilov, T. Mirzabekov, and H. Choe. 2002. The role of post-translational modifications of the CXCR4 amino terminus in stromal-derived factor 1 α association and HIV-1 entry. J. Biol. Chem. 277: 29484-29489.
23. Farzan, M., T. Mirzabekov, P. Kolchinsky, R. Wyatt, M. Cayabyab, N. P. Gerard, C. Gerard, J. Sodroski, and H. Choe. 1999. Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry. Cell 96: 667-676.
24. Lapham, C. K., M. B. Zaitseva, S. Lee, T. Romanstseva, and H. Golding. 1999. Fusion of monocytes and macrophages with HIV-1 correlates with biochemical properties of CXCR4 and CCR5. Nat. Med. 5: 303-308.
25. Wang, J., L. He, C. A. Combs, G. Roderiquez, and M. A. Norcross. 2006. Dimerization of CXCR4 in living malignant cells: control of cell migration by a synthetic peptide that reduces homologous CXCR4 interactions. Mol. Cancer Ther. 5: 2474-2483.
26. Valenzuela-Fernandez, A., T. Planchenault, F. Baleux, I. Staropoli, K. Le-Barillec, D. Leduc, T. Delaunay, F. Lazarini, J. L. Virelizier, M. Chignard, et al. 2002. Leukocyte elastase negatively regulates stromal cell-derived factor-1 (SDF-1)/CXCR4 binding and functions by amino-terminal processing of SDF-1 and CXCR4. J. Biol. Chem. 277: 15677-15689.
27. Levesque, J. P., J. Hendy, Y. Takamatsu, P. J. Simmons, and L. J. Bendall. 2003. Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. J. Clin. Invest. 111: 187-196.
28. Lapidot, T., and I. Petit. 2002. Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. Exp. Hematol. 30: 973-981.
29. Baribaud, F., T. G. Edwards, M. Sharron, A. Brelot, N. Heveker, K. Price, F. Mortari, M. Alizon, M. Tsang, and R. W. Doms. 2001. Antigenically distinct conformations of CXCR4. J. Virol. 75: 8957-8967.
30. Carnec, X., L. Quan, W. C. Olson, U. Hazan, and T. Dragic. 2005. Anti-CXCR4 monoclonal antibodies recognizing overlapping epitopes differ significantly in their ability to inhibit entry of human immunodeficiency virus type 1. J. Virol. 79: 1930-1933.
31. Choe, H., W. Li, P. L. Wright, N. Vasilieva, M. Venturi, C. C. Huang, C. Grundner, T. Dorfman, M. B. Zwick, L. Wang, et al. 2003. Tyrosine sulfation of human antibodies contributes to recognition of the CCR5 binding region of HIV-1 gp120. Cell 114: 161-170.
32. Huang, C. C., M. Venturi, S. Majeed, M. J. Moore, S. Phogat, M. Y. Zhang, D. S. Dimitrov, W. A. Hendrickson, J. Robinson, J. Sodroski, et al. 2004. Structural basis of tyrosine sulfation and VH-gene usage in antibodies that recognize the HIV type 1 coreceptor-binding site on gp120. Proc. Natl. Acad. Sci. USA 101: 2706-2711.
33. Hsu, W., G. L. Rosenquist, A. A. Ansari, and M. E. Gershwin. 2005. Autoimmunity and tyrosine sulfation. Autoimmun. Rev. 4: 429-435.
34. Babcock, G. J., T. Mirzabekov, W. Wojtowicz, and J. Sodroski. 2001. Ligand binding characteristics of CXCR4 incorporated into paramagnetic proteoliposomes. J. Biol. Chem. 276: 38433-38440.
35. Mirzabekov, T., H. Kontos, M. Farzan, W. Marasco, and J. Sodroski. 2000. Paramagnetic proteoliposomes containing a pure, native, and oriented seven-transmembrane segment protein, CCR5. Nat. Biotechnol. 18: 649-654.
36. Bai, J., J. Sui, R. Y. Zhu, A. S. Tallarico, F. Gennari, D. Zhang, and W. A. Marasco. 2003. Inhibition of Tat-mediated transactivation and HIV-1 replication by human anti-hCyclinT1 intrabodies. J. Biol. Chem. 278: 1433-1442.
37. Doranz, B. J., M. J. Orsini, J. D. Turner, T. L. Hoffman, J. F. Berson, J. A. Hoxie, S. C. Peiper, L. F. Brass, and R. W. Doms. 1999. Identification of CXCR4 domains that support coreceptor and chemokine receptor functions. J. Virol. 73: 2752-2761.
38. H joining mechanism in heavy-chain-negative (null) pre-B cells results in heavy-chain production. Nature 322: 840-842.
39. Radic, M. Z., and M. Zouali. 1996. Receptor editing, immune diversification, and self-tolerance. Immunity 5: 505-511.
40. Nemazee, D., and M. Weigert. 2000. Revising B cell receptors. J. Exp. Med. 191: 1813-1817.
41. h gene replacement to the primary B cell repertoire. Immunity 19: 21-31.
42. Lu, Z., J. F. Berson, Y. Chen, J. D. Turner, T. Zhang, M. Sharron, M. H. Jenks, Z. Wang, J. Kim, J. Rucker, et al. 1997. Evolution of HIV-1 coreceptor usage through interactions with distinct CCR5 and CXCR4 domains. Proc. Natl. Acad. Sci. USA 94: 6426-6431.
43. Brelot, A., N. Heveker, K. Adema, M. J. Hosie, B. Willett, and M. Alizon. 1999. Effect of mutations in the second extracellular loop of CXCR4 on its utilization by human and feline immunodeficiency viruses. J. Virol. 73: 2576-2586.
44. Moore, K. L. 2003. The biology and enzymology of protein tyrosine O-sulfation. J. Biol. Chem. 278: 24243-24246.
45. Monigatti, F., E. Gasteiger, A. Bairoch, and E. Jung. 2002. The Sulfinator: predicting tyrosine sulfation sites in protein sequences. Bioinformatics 18: 769-770.
46. Mintz, K. P., L. W. Fisher, W. J. Grzesik, V. C. Hascall, and R. J. Midura. 1994. Chlorate-induced inhibition of tyrosine sulfation on bone sialoprotein synthesized by a rat osteoblast-like cell line (UMR 106-01 BSP). J. Biol. Chem. 269: 4845-4852.
47. Osbourn, J. K., E. J. Derbyshire, T. J. Vaughan, A. W. Field, and K. S. Johnson. 1998. Pathfinder selection: in situ isolation of novel antibodies. Immunotechnology 3: 293-302.
48. Osbourn, J. K., J. C. Earnshaw, K. S. Johnson, M. Parmentier, V. Timmermans, and J. McCafferty. 1998. Directed selection of MIP-1α neutralizing CCR5 antibodies from a phage display human antibody library. Nat. Biotechnol. 16: 778-781.
49. Sui, J., J. Bai, A. St Clair Tallarico, C. Xu, and W. A. Marasco. 2003. Identification of CD4 and transferrin receptor antibodies by CXCR4 antibody-guided Pathfinder selection. Eur. J. Biochem. 270: 4497-4506.
50. Vaday, G. G., S. B. Hua, D. M. Peehl, M. H. Pauling, Y. H. Lin, L. Zhu, D. M. Lawrence, H. D. Foda, and S. Zucker. 2004. CXCR4 and CXCL12 (SDF-1) in prostate cancer: inhibitory effects of human single chain Fv antibodies. Clin. Cancer Res. 10: 5630-5639.
51. H replacement. Immunol. Rev. 197: 231-242.
52. Nussenzweig, M. C. 1998. Immune receptor editing: revise and select. Cell 95: 875-878.
53. King, L. B., and J. G. Monroe. 2001. Immunology: B cell receptor rehabilitation - pausing to reflect. Science 291: 1503-1505.
54. H gene replacement in immunity and disease. Ann. NY Acad. Sci. 1062: 175-181.
55. Kenakin, T. 2004. Principles: receptor theory in pharmacology. Trends Pharmacol. Sci. 25: 186-192.
56. 262 of the chemokine receptor CXCR4 impairs its coreceptor function for human immunodeficiency virus-1 entry and abrogates the antagonistic activity of AMD3100. Mol. Pharmacol. 60: 164-173.
57. Gerlach, L. O., R. T. Skerlj, G. J. Bridger, and T. W. Schwartz. 2001. Molecular interactions of cyclam and bicyclam non-peptide antagonists with the CXCR4 chemokine receptor. J. Biol. Chem. 276: 14153-14160.
58. Brelot, A., N. Heveker, M. Montes, and M. Alizon. 2000. Identification of residues of CXCR4 critical for human immunodeficiency virus coreceptor and chemokine receptor activities. J. Biol. Chem. 275: 23736-23744.
59. Zhou, N., Z. Luo, J. Luo, D. Liu, J. W. Hall, R. J. Pomerantz, and Z. Huang. 2001. Structural and functional characterization of human CXCR4 as a chemokine receptor and HIV-1 co-receptor by mutagenesis and molecular modeling studies. J. Biol. Chem. 276: 42826-42833.
60. Lapidot, T., A. Dar, and O. Kollet. 2005. How do stem cells find their way home? Blood 106: 1901-1910.
61. Dar, A., O. Kollet, and T. Lapidot. 2006. Mutual, reciprocal SDF-1/CXCR4 interactions between hematopoietic and bone marrow stromal cells regulate human stem cell migration and development in NOD/SCID chimeric mice. Exp. Hematol. 34: 967-975.
62. Shepherd, R. M., B. J. Capoccia, S. M. Devine, J. Dipersio, K. M. Trinkaus, D. Ingram, and D. C. Link. 2006. Angiogenic cells can be rapidly mobilized and efficiently harvested from the blood following treatment with AMD3100. Blood 108: 3662-3667.
63. + hemangiocytes. Nat. Med. 12: 557-567.
64. Imai, K., M. Kobayashi, J. Wang, N. Shinobu, H. Yoshida, J. Hamada, M. Shindo, F. Higashino, J. Tanaka, M. Asaka, and M. Hosokawa. 1999. Selective secretion of chemoattractants for haemopoietic progenitor cells by bone marrow endothelial cells: a possible role in homing of haemopoietic progenitor cells to bone marrow. Br. J. Haematol. 106: 905-911.
65. Dar, A., P. Goichberg, V. Shinder, A. Kalinkovich, O. Kollet, N. Netzer, R. Margalit, M. Zsak, A. Nagler, I. Hardan, et al. 2005. Chemokine receptor CXCR4-dependent internalization and resecretion of functional chemokine SDF-1 by bone marrow endothelial and stromal cells. Nat. Immunol. 6: 1038-1046.
66. Kalinkovich, A., S. Tavor, A. Avigdor, J. Kahn, A. Brill, I. Petit, P. Goichberg, M. Tesio, N. Netzer, E. Naparstek, et al. 2006. Functional CXCR4-expressing microparticles and SDF-1 correlate with circulating acute myelogenous leukemia cells. Cancer Res. 66: 11013-11020.
67. Janowska-Wieczorek, A., M. Majka, J. Kijowski, M. Baj-Krzyworzeka, R. Reca, A. R. Turner, J. Ratajczak, S. G. Emerson, M. A. Kowalska, and M. Z. Ratajczak. 2001. Platelet-derived microparticles bind to hematopoietic stem/progenitor cells and enhance their engraftment. Blood 98: 3143-3149.